GC-MS Instrument Repair

The Drug Enforcement Administration (DEA) is seeking a sole source acquisition for the repair of a GC-MS instrument. The instrument is mission-critical, and the DEA intends to award a firm-fixed price purchase order to Agilent Technologies, Inc. The acquisition is being pursued on a sole source basis because Agilent is the manufacturer of the instrument and has the necessary expertise to complete the repair. • The instrument is used for casework and is essential to the DEA's operations. • The repair is expected to be completed within a period of performance from November 26, 2025, to November 25, 2026. • The DEA is seeking a sole source acquisition due to the unique requirements of the instrument and the lack of other available sources. • The estimated total amount of the acquisition is not specified, but it is expected to exceed $25,000.